← European Medicine Shortage Tracker · all medicines
Fosfomycin-Natrium (Ph.Eur.) currently has availability issues reported in 1 European register: Germany.
Shortage ATC J01XX01 · also listed as: Fosfomycin-Natrium (Ph.Eur.) · data refreshed 7 August 2026
As of 7 August 2026, 1 of the 10 tracked registers list current availability issues for Fosfomycin-Natrium (Ph.Eur.), covering 2 affected product presentations. The longest-running open report was filed in Germany on 2024-11-05 and has now been open for about 21 months. The furthest expected-resolution date currently on file is 2026-09-30; the earliest is 2026-09-30. Registers in Germany indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Fosfomycin-Natrium (Ph.Eur.) is coded J01XX01 — a medicine acting on anti-infectives for systemic use — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇩🇪 Germany | Shortage Fosfomycin Eberth 2 g Pulver zur Herstellung einer Infusionslösung + 1 more productsFosfomycin Eberth 4 g Pulver zur Herstellung einer Infusionslösung | 2024-11-05 | 2026-09-30 | Sonstige Alternatives: Fosfomycin Eberth 2 g Pulver zur Herstellung einer Infusionslösung - Einreichungsnummer: 2203902 | register ↗ |
Every individual register entry for Fosfomycin-Natrium (Ph.Eur.) in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇩🇪 DE | Fosfomycin Eberth 2 g Pulver zur Herstellung einer Infusionslösung | Shortage | 2024-11-05 | 2026-09-30 | Sonstige |
| 🇩🇪 DE | Fosfomycin Eberth 4 g Pulver zur Herstellung einer Infusionslösung | Shortage | 2024-11-05 | 2026-09-30 | Sonstige |
Yes. As of 7 August 2026, availability issues are reported in: Germany. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-09-30 to 2026-09-30. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
2 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency register that lists Fosfomycin-Natrium (Ph.Eur.): BfArM (Germany). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Fosfomycin-Natrium (Ph.Eur.) — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/fosfomycin-natrium-ph-eur/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Fosfomycin-Natrium (Ph.Eur.) availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/fosfomycin-natrium-ph-eur/">Fosfomycin-Natrium (Ph.Eur.) shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>